Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test

References

• Bush K, Bradford PA. β-Lactams and β-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med. 2016;6:a025247. doi:10.1101/cshperspect.a025247
   PubMed Web of Science ®Google Scholar
• Drawz SM, Bonomo RA. Three decades of β-lactamase inhibitors. Clin Microbiol Rev. 2010;23:160–201. doi:10.1128/CMR.00037-09
   PubMed Web of Science ®Google Scholar
• Rodríguez-Villodres Á, de la Rosa JM O, Alvarez-Marín R, et al. Heteroresistance to piperacillin-tazobactam in clinical isolates of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2017;62:e01923.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Villodres Á, Gil-Marqués ML, Alvarez-Marín R, et al. Extended-spectrum resistance to β-lactams/β lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli. J Antimicrob Chemother. 2020;75:77–85.
   PubMed Web of Science ®Google Scholar
• Shubert C, Slaughter J, Creely D, et al. Population analysis of Escherichia coli isolates with discordant resistance levels by piperacillin-tazobactam broth microdilution and agar dilution testing. Antimicrob Agents Chemother. 2014;58:1779–1781. doi:10.1128/AAC.02181-13
   PubMed Web of Science ®Google Scholar
• Schechter LM, Creely DP, Garner CD, et al. Extensive gene amplification as a mechanism for piperacillin-tazobactam resistance in Escherichia coli. mBio. 2018;9:e00583–182018. doi:10.1128/mBio.00583-18
   PubMed Web of Science ®Google Scholar
• Hansen KH, Rud Andreasen M, et al. Resistance to piperacillin/tazobactam in Escherichia coli resulting from extensive IS26-associated gene amplification of blaTEM-1. J Antimicrob Chemother. 2019;74:3179–3183. doi:10.1093/jac/dkz349
   PubMed Web of Science ®Google Scholar
• Hubbard ATM, Mason J, Roberts P, et al. Piperacillin/tazobactam resistance in a clinical isolate of escherichia coli due to IS26-mediated amplification of blaTEM-1B. Nat Commun. 2020;11:4915. doi:10.1038/s41467-020-18668-2
   PubMed Web of Science ®Google Scholar
• Zhou K, Tao Y, Han L, et al. Piperacillin-tazobactam (TZP) resistance in Escherichia coli due to hyperproduction of TEM-1 β-lactamase mediated by the promoter Pa/Pb. Front Microbiol. 2019;10:833. doi:10.3389/fmicb.2019.00833
   PubMed Web of Science ®Google Scholar
• Chaibi EB, Sirot D, Paul G, et al. Inhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother. 1999;43:447–458. doi:10.1093/jac/43.4.447
   PubMed Web of Science ®Google Scholar
• Henderson A, Patersin DL, Chatfield MD, et al. Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study. Clin Infect Dis. 2021;73:e3842–e3850. doi:10.1093/cid/ciaa1479
   PubMed Web of Science ®Google Scholar
• Livermore DM, Day M, Cleary P, et al. OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producingescherichia coli. J Antimicrob Chemother. 2019;74:326–333. doi:10.1093/jac/dky453
   PubMed Web of Science ®Google Scholar
• Bethel CR, Hujer AM, Helfand MS, et al. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and b-lactamase inhibition. FEMS Microbiol Lett. 2004;234:99–103.
   PubMed Web of Science ®Google Scholar
• Vimont S, Aubert D, Mazoit JX, et al. Broad-spectrum -lactams for treating experimental peritonitis in mice due to escherichia coli producing plasmid-encoded cephalosporinases. J Antimicrob Chemother. 2007;60:1045–1050. doi:10.1093/jac/dkm317
   PubMed Web of Science ®Google Scholar
• Pagès JM, Jame CE, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in gram-negative bacteria. Nat Rev Microbiol. 2008;6:893–903. doi:10.1038/nrmicro1994
   PubMed Web of Science ®Google Scholar
• Monogue ML, Tanner LK, Brecher SM, et al. Detection of piperacillin-tazobactam-resistant/Pan-β-lactam-susceptibleescherichia coliwith current automated susceptibility test systems. Infection Control & Hospital Epidemiology. 2017;38:379–338. doi:10.1017/ice.2016.325
   PubMed Web of Science ®Google Scholar
• Pulido MR, García-Quintanilla M, Martín-Peña R, et al. Progress on the development of rapid methods for antimicrobial susceptibility testing. J Antimicrob Chemother. 2013;68:2710–2717. doi:10.1093/jac/dkt253
   PubMed Web of Science ®Google Scholar
• Shelburne SA, Kim J, Munita JM, et al. Whole-Genome sequencing accurately identifies resistance to extended-spectrum β-lactams for major gram-negative bacterial pathogens. Clin Infect Dis. 2017;65:738–745. doi:10.1093/cid/cix417
   PubMed Web of Science ®Google Scholar
• Rodríguez-Villodres A, Gutiérrez-Linares A, Gálvez-Benítez L, et al. Semirapid detection of piperacillin/tazobactam resistance and extended-spectrum resistance to β-lactams/β-lactamase inhibitors in clinical isolates of escherichia coli. Microbiol Spectr. 2021;9:e0080121. doi:10.1128/Spectrum.00801-21
   PubMed Web of Science ®Google Scholar
• Dortet L, Bonnin RA, Pennisi I, et al. Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. J Antimicrob Chemother. 2018;73:3359–3367.
   PubMed Web of Science ®Google Scholar
• Dortet L, Potron A, Bonnin RA, et al. Rapid detection of colistin resistance in acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria. Sci Rep. 2018;8:16910. doi:10.1038/s41598-018-35041-y
   PubMed Web of Science ®Google Scholar
• Dortet L, Broda A, Bernabeu S, et al. Optimization of the MALDIxin test for the rapid identification of colistin resistance in klebsiella pneumoniae using MALDI-TOF MS. J Antimicrob Chemother. 2020;75:110–116. doi:10.1093/jac/dkz405
   PubMed Web of Science ®Google Scholar
• Dortet L, Bonnin RA, Le Hello S, et al. Detection of colistin resistance in salmonella enterica using MALDIxin test on the routine MALDI biotyper sirius mass spectrometer. Front Microbiol. 2020;11:1141. doi:10.3389/fmicb.2020.01141
   PubMed Web of Science ®Google Scholar
• Rhoads DD, Wang H, Karichu J, et al. The presence of a single MALDI-TOF mass spectral peak predicts methicillin resistance in staphylococci. Diagn Microbiol Infect Dis. 2016;86:257–261. doi:10.1016/j.diagmicrobio.2016.08.001
   PubMed Web of Science ®Google Scholar
• Gato E, Constanso IP, Candela A, et al. An improved matrix-assisted laser desorption ionization-time of flight mass spectrometry data analysis pipeline for the identification of carbapenemase375 producing Klebsiella pneumoniae. J Clin Microbiol. 2021;59:e0080021.
   PubMed Web of Science ®Google Scholar
• Dortet L, Tandé D, de Briel D, et al. MALDI-TOF for the rapid detection of carbapenemase-producing enterobacteriaceae: comparison of the commercialized MBT STAR®-Carba IVD Kit with two in-house MALDI-TOF techniques and the RAPIDEC® CARBA NP. J Antimicrob Chemother. 2018;73:2352–2359. doi:10.1093/jac/dky209
   PubMed Web of Science ®Google Scholar
• Lau AF, Wang H, Weingarten RA, et al. A rapid matrix-assisted laser desorption ionization–time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant enterobacteriaceae. J Clin Microbiol. 2014;52:2804–2812. doi:10.1128/JCM.00694-14
   PubMed Web of Science ®Google Scholar
• European Society of Clinical Microbiology and Infectious Diseases. Media preparation for EUCAST disk diffusion testing and for determination of MIC values by the broth microdilution method [cited 2021, Dec 12]. https://www.eucast.org/ast_of_bacteria/disk_diffusion_methodology/.
   Google Scholar
• Harris PNA, Tambyah PA, Lye DC, et al. Effect of piperacillin-tazobactam vs meropenem on 30-Day mortality for patients WithE coliorklebsiella pneumoniaebloodstream infection and ceftriaxone resistance. JAMA. 2018;320:984–994. doi:10.1001/jama.2018.12163
   PubMed Web of Science ®Google Scholar
• Anton-Vazquez V, Adjepon S, Suarez C, et al. Evaluation of a new rapid antimicrobial susceptibility system for gram-negative and gram-positive bloodstream infections: speed and accuracy of Alfred 60AST. BMC Microbiol. 2019;19:268. doi:10.1186/s12866-019-1654-9
   PubMed Web of Science ®Google Scholar
• Jonasson E, Matuschek E, Kahlmeter G. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother. 2020;75:968–978. doi:10.1093/jac/dkz548
   PubMed Web of Science ®Google Scholar
• Akerlund A, Jonasson E, Matuschek E, et al. EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories. J Antimicrob Chemother. 2020;75:3230–3238. doi:10.1093/jac/dkaa333
   PubMed Web of Science ®Google Scholar
• Croxatto A, Prod'hom G, Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 2012;36:380–407. doi:10.1111/j.1574-6976.2011.00298.x
   PubMed Web of Science ®Google Scholar
• Oviaño M, Bou G. Matrix-Assisted laser desorption ionization-time of flight mass spectrometry for the rapid detection of antimicrobial resistance mechanisms and beyond. Clin Microbiol Rev. 2018;32(1):e00037–18. doi:10.1128/CMR.00037-18
   PubMed Web of Science ®Google Scholar
• Weis C, Cuénod A, Rieck B, et al. Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning. Nat Med. 2022;28:164–174. doi:10.1038/s41591-021-01619-9
   PubMed Web of Science ®Google Scholar